Lastly, a better mechanistic understanding of the CERK/5-oxo-ETE interplay could be valuable for treating other diseases highly correlated to these lipid biomarkers such as preeclampsia (68, 69) and type 1 diabetes (70, 71). This evidence concerns the gene CERK and preeclampsia.